Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 14
Encontrada(s) 1 página(s)

RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

Modeling the Number of People Infected With SARS-COV-2 From Wastewater Viral Load in Northwest Spain

  • Vallejo, J. A.
  • Trigo Tasende, Noelia
  • Rumbo-Feal, Soraya
  • Conde-Pérez, Kelly
  • López-Oriona, Ángel
  • Barbeito, Inés
  • Vaamonde, Manuel
  • Tarrío-Saavedra, Javier
  • Reif López, Rubén
  • Ladra, Susana
  • Rodiño-Janeiro, Bruno Kotska
  • Nasser-Ali, Mohammed
  • Cid, Ángeles
  • Veiga, María Carmen
  • Acevedo, Antón
  • Lamora, Carlos
  • Bou, Germán
  • Cao, Ricardo
  • Poza, Margarita
Financiado para publicación en acceso aberto: Universidade da Coruña/CISUG, [Abstract] The quantification of the SARS-CoV-2 RNA load in wastewater has emerged as a useful tool to monitor COVID–19 outbreaks in the community. This approach was implemented in the metropolitan area of A Coruña (NW Spain), where wastewater from a treatment plant was analyzed to track the epidemic dynamics in a population of 369,098 inhabitants. Viral load detected in the wastewater and the epidemiological data from A Coruña health system served as main sources for statistical models developing. Regression models described here allowed us to estimate the number of infected people (R2 = 0.9), including symptomatic and asymptomatic individuals. These models have helped to understand the real magnitude of the epidemic in a population at any given time and have been used as an effective early warning tool for predicting outbreaks in A Coruña municipality. The methodology of the present work could be used to develop a similar wastewater-based epidemiological model to track the evolution of the COVID–19 epidemic anywhere in the world where centralized water-based sanitation systems exist., This work was supported by EDAR Bens S.A., A Coruña, Spain [grant references INV04020, INV12120 and INV05921 to MP], the National Plan for Scientific Research, Development and Technological Innovation 2013-2016 funded by the ISCIII, Spain - General Subdirection of Assessment and Promotion of the Research-European Regional Development Fund (FEDER) “A way of making Europe” [grant numbers PI15/00860 to GB, PI17/01482 and PI20/00413 to MP], the GAIN, Xunta de Galicia, Spain [grant number IN607A 2016/22 to GB, ED431C-2016/015 and ED431C-2020/14 to RC, ED431C 2017/58 to SL, ED431G 2019/01 to RC and SL, and ED431C 2017/66 to MCV], MINECO, Spain [grant number MTM2017-82724-R to RC], Ministerio de Ciencia e Innovación, Spain [grant number PID2020-113578RB-100 to RC], and the Spanish Network for Research in Infectious Diseases [REIPI RD16/0016/006 to GB]. The work was also supported by the European Virus Archive Global (EVA-GLOBAL) project that has received funding from the European Union's Horizon 2020 - Research and Innovation Framework Programme under grant agreement no 871029. SR-F was financially supported by REIPI RD16/0016/006, KC-P by IN607A 2016/22 and the Spanish Association against Cancer (AECC) and JAV by IN607A 2016/22. Funding for open access charge: Universidade da Coruña/CISUG, EDAR Bens S.A.; INV04020, EDAR Bens S.A.; INV12120, EDAR Bens S.A.; INV05921, Xunta de Galicia; IN607A 2016/22, Xunta de Galicia; ED431C-2016/015, Xunta de Galicia; ED431C-2020/14, Xunta de Galicia; ED431C 2017/58, Xunta de Galicia; ED431G 2019/01, Xunta de Galicia; ED431C 2017/66
RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

Emergence of Carbapenemase Genes in Gram-Negative Bacteria Isolated from the Wastewater Treatment Plant in A Coruña, Spain

  • Nasser-Ali, Mohammed
  • Aja-Macaya, Pablo
  • Conde-Pérez, Kelly
  • Trigo Tasende, Noelia
  • Rumbo-Feal, Soraya
  • Fernández González, Ana
  • Bou, Germán
  • Poza, Margarita
  • Vallejo, J. A.
[Abstract] Wastewater treatment plants (WWTPs) are recognized as important niches of antibiotic-resistant bacteria that can be easily spread to the environment. In this study, we collected wastewater samples from the WWTP of A Coruña (NW Spain) from April 2020 to February 2022 to evaluate the presence of Gram-negative bacteria harboring carbapenemase genes. Bacteria isolated from wastewater were classified and their antimicrobial profiles were determined. In total, 252 Gram-negative bacteria carrying various carbapenemase genes were described. Whole-genome sequencing was conducted on 55 selected carbapenemase producing isolates using Oxford Nanopore technology. This study revealed the presence of a significant population of bacteria carrying carbapenemase genes in WWTP, which constitutes a public health problem due to their risk of dissemination to the environment. This emphasizes the usefulness of WWTP monitoring for combating antibiotic resistance. Data revealed the presence of different types of sequences harboring carbapenemase genes, such as blaKPC-2, blaGES-5, blaGES-6, blaIMP-11, blaIMP-28, blaOXA-24, blaOXA-48, blaOXA-58, blaOXA-217, and blaVIM-2. Importantly, the presence of the blaKPC-2 gene in wastewater, several months before any clinical case was detected in University Hospital of A Coruña, suggests that wastewater-based epidemiology can be used as an early warning system for the surveillance of antibiotic-resistant bacteria., The present study received funding from the Instituto de Salud Carlos III (ISCIII), Spain, through the project PI20/00413, co-funded by the European Union (EU) to M.P. and by CIBER de Enfermedades Infecciosas: CIBERINFEC, ISCIII (CB21/13/00055) to G.B and M.P.
RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

Metatranscriptomic analysis of the microbiota of tumor tissue in colon cancer

  • Buetas, Elena
  • Conde-Pérez, Kelly
  • Concha López, Ángel
  • Celeiro, Catuxa
  • Noguera, José
  • Bou, Germán
  • Pardiñas López, Simón
  • Vallejo, J. A.
  • Poza, Margarita
  • Carda-Diéguez, Miguel
  • Mira, Alex
[Abstract] Background: Colorectal cancer (CRC) is the second leading cause of cancer-related deaths, accounting for more than 900,000 deaths a year worldwide. Microbial dysbiosis, including the presence of oral bacteria in the gut, has been linked to CRC. Some mechanisms by which specific microorganisms potentially drive tumorigenesis have been described, but there is a lack of studies elucidating whole microbiota activity in the tumor and their implication for the development of the disease. Here, the metatranscriptomic data of tumor and control tissue-associated microbiota (n = 18 pairs), as well as from subgingival sulcus (n = 15) of CRC patients, was analyzed. Results: We confirmed that Fusobacterium nucleatum was more active in the tumor tissue than in the control gut mucosa. In addition, the activity of this species was positively correlated with other oral bacteria in the tumors, including Parvimonas micra, Peptostreptococcus stomatis, and Granulicatella adiacens, along with gut bacteria like Hungatella hathewayi, suggesting a potential relationship among them. Regarding bacterial gene expression, a change in the functional profile was observed, including a higher expression of genes associated with carbon metabolism in control in contrast to an increase of amino acid-related genes in tumor. Furthermore, genes implicated in the biosynthesis and transport of lipopolysaccharide were increased in tumors. Interestingly, a significantly higher expression in tumor than control tissue of potential virulence factors from F. nucleatum was found, supporting their relevance in niche colonization and tumorigenesis. Correlation analysis of the bacterial activity with the host transcriptional profile showed significant correlations of the Fusobacterium-Peptostreptotoccus-Hungatella cluster with human genes involved in inflammation and metastasis, confirming the association of this microbial consortium with tumor development. For the first time, the gene expression profiles of oral bacteria in the gut and the oral cavity were compared. The cluster of co-active bacteria identified in tumors was partially found in the oral samples, suggesting a stable interaction and potential synergy. Although there were thousands of differentially expressed genes between subgingival sulcus and tumor tissue, the expression of key virulence factors was not significantly different. Conclusions: In short, this study discovered new traits about tumor microbial-associated composition and activity and its connection with the oral composition that would be essential to unravel the translocation, colonization, and tumorigenesis of the CRC. Video Abstract., This work has been supported by the project RTI2018‐102032‐B‐I00 from the Spanish Ministry of Science and Innovation to AM. EB was supported by a grant from the Spanish Ministry of Science and Innovation PRE2019‐088126. In addition, the present study received funding from the Instituto de Salud Carlos III (ISCIII), Spain, through the projects PI20/00413 and PI23/00696, co-financed by the European Union (EU) to MP. KC was financially supported by the Spanish Association against Cancer (AECC).
RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

Microbiome Differential Abundance Methodologies to Detect Relevant Taxa Associated with Chemotherapy Toxicity Rate in Colorectal Cancer

  • Martin-De Arribas, E.
  • Conde-Pérez, Kelly
  • Aja-Macaya, Pablo
  • Vallejo, J. A.
  • Bou, Germán
  • López-Cheda, Ana
  • Jácome, M. A.
  • Ladra, Susana
  • Poza, Margarita
Financiado para publicación en acceso aberto: Universidade da Coruña/CISUG The data supporting this study are publicly available in the National Centre for Biotechnology Information (NCBI) Sequence Read Archive (SRA) database under the accession codes PRJNA911189 and PRJNA893853. The complete metadata set used in this paper is available in our GitHub repository (see Section 2.6). The external validation dataset used in this study will be available in the GitHub repository for this paper (see Section 2.6). At the same time, it can be downloaded directly from the original paper (Hillege et al. 2025). Supplementary material is available at Bioinformatics Advances online., [Abstract]: Motivation. The interplay between microbial communities and treatment outcomes represents a promising area in pharmacomicrobiomics. Identifying microbial biomarkers that differentiate toxicity levels could inform personalized cancer strategies. However, biomarker identification is strongly influenced by methodological choices in differential abundance analysis (DAA), and most studies focus on individual outcomes despite toxicity being inherently multifactorial. In this study, we defined a multi-dimensional toxicity variable integrating clinical symptoms and treatment modifications to stratify colorectal cancer patients. We then evaluated six widely used DAA methods (ALDEx2, ANCOM-BC, DESeq2, LEfSe, LinDA, and ZicoSeq) to assess how analytical variability affects the detection of microbiome signatures associated with chemotherapy-related toxicity. Analyses were performed under different preprocessing and multiple-testing correction strategies, and consistency was further examined using an independent validation dataset. Results. Substantial variability was observed across methods, with limited overlap in detected taxa but moderate concordance in effect-size rankings. ANCOM-BC showed the most consistent overall performance across analytical scenarios, although trade-offs remained between taxa detection, ranking, and direction of association. Despite this variability, a subset of taxa was consistently identified across methods, including Parvimonas, Eubacterium ventriosum group, and Ruminococcus in the low-toxicity group, and members of the Lachnospiraceae family, such as Fusicatenibacter, Lachnospira, and the Lachnospiraceae NK4A136 group, in the severe-toxicity group. Analyses in the external validation dataset supported the reproducibility of methodological patterns, despite differences in cohort composition and sequencing strategy. These findings highlight the methodological dependence of microbiome biomarker discovery and the potential of pre-treatment microbial signatures to stratify toxicity risk. View collectively, our results support a context-dependent approach to DAA method selection in clinical microbiome studies., This work was supported by the Spanish Ministry of Science and Innovation with funds from the European Union NextGenerationEU; GAIN and MRR funds, Recovery, Transformation and Resilience Plan (PRTRC17.I1) and from the Autonomous Community of Galicia within the framework of the Biotechnology Plan Applied to Health (DATAMICROCCR); GAIN/Xunta de Galicia (GRC: ED431C 2025/34, ED431C-2024/14); grant PID2023-147127OB-I00, funded by MCIN/ AEI/10.13039/501100011033/; and the Xunta de Galicia through the collaboration agreement between the Department of Culture, Education, Vocational Training and Universities and the Galician universities for the reinforcement of the research centres of the Galician University System, CIGUS (CITIC). This study also received funding from the Instituto de Salud Carlos III (ISCIII), Spain, through the projects PI20/00413 and PI23/00696, co-funded by the European Union [to M.P.]. Finally, project IN607A 2024/09, awarded to G.B., also funded this research. Funding for open access charge: Universidade da Coruña/CISUG., Xunta de Galicia; ED431C 2025/34, Xunta de Galicia; ED431C-2024/14, Xunta de Galicia; IN607A 2024/09, https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/bioinformaticsadvances/6/1/10.1093_bioadv_vbag148/1/vbag148_supplementary_data.pdf?Expires=1786057871&Signature=3JyWGTBNJMk04Mo5YA478REuErHCckTX6BI6fB6LVUetTCLbgdQT2flCwWz3IJduY3I0wJGqrcGVq1LgHo5M3e8jAQggncSqnXBgVbCB~TCudFbcDFAKw3i8rF34P56E58L4krtm0F8cRDuW3WwGPZUvqxlETfuGcCUBU9XkLTLyOojjwVw78QXwxPN80aqHX9qNlKvwfcsVdRh52UpoK1rCRUHFQQrSGevPmMBL0M4tiCKg~CX7kUolD8o3BZvyKe4QzGXro7pEZYfRybU53ke-R3t0b05bo-oIK0xqkCwDqMhZZgriJYrleG1hpgW8EZ1Iyy3iwi7g4O86QmwrZQ__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA
RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

Wastewater early warning system for SARS-CoV-2 outbreaks and variants in a Coruña, Spain

  • Trigo Tasende, Noelia
  • Vallejo, J. A.
  • Rumbo-Feal, Soraya
  • Conde-Pérez, Kelly
  • Vaamonde, Manuel
  • López-Oriona, Ángel
  • Barbeito, Inés
  • Nasser-Ali, Mohammed
  • Reif López, Rubén
  • Rodiño-Janeiro, Bruno Kotska
  • Fernández-Álvarez, Elisa
  • Iglesias Corrás, Iago
  • Tarrío-Saavedra, Javier
  • Tomás, Laura
  • Gallego-García, Pilar
  • Posada, David
  • Bou, Germán
  • López-de-Ullibarri, Ignacio
  • Cao, Ricardo
  • Susana, Ladra
  • Poza, Margarita
Financiado para publicación en acceso aberto: Universidade da Coruña/CISUG, [Abstract]: Wastewater-based epidemiology has been widely used as a cost-effective method for tracking the COVID-19 pandemic at the community level. Here we describe COVIDBENS, a wastewater surveillance program running from June 2020 to March 2022 in the wastewater treatment plant of Bens in A Coruña (Spain). The main goal of this work was to provide an effective early warning tool based in wastewater epidemiology to help in decision-making at both the social and public health levels. RT-qPCR procedures and Illumina sequencing were used to weekly monitor the viral load and to detect SARS-CoV-2 mutations in wastewater, respectively. In addition, own statistical models were applied to estimate the real number of infected people and the frequency of each emerging variant circulating in the community, which considerable improved the surveillance strategy. Our analysis detected 6 viral load waves in A Coruña with concentrations between 103 and 106 SARS-CoV-2 RNA copies/L. Our system was able to anticipate community outbreaks during the pandemic with 8-36 days in advance with respect to clinical reports and, to detect the emergence of new SARS-CoV-2 variants in A Coruña such as Alpha (B.1.1.7), Delta (B.1.617.2), and Omicron (B.1.1.529 and BA.2) in wastewater with 42, 30, and 27 days, respectively, before the health system did. Data generated here helped local authorities and health managers to give a faster and more efficient response to the pandemic situation, and also allowed important industrial companies to adapt their production to each situation. The wastewater-based epidemiology program developed in our metropolitan area of A Coruña (Spain) during the SARS-CoV-2 pandemic served as a powerful early warning system combining statistical models with mutations and viral load monitoring in wastewater over time., Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature. Funding for open access charge: Universidade da Coruña/CISUG. This work was supported by EDAR Bens S.A., A Coruña, Spain [grant references INV04020, INV12120, INV05921, and INV148721 to MP], by the National Plan for Scientific Research, Development and Technological Innovation funded by the Institute of Health Carlos III (ISCIII), Spain—General Subdirection of Assessment and Promotion of the Research-European Regional Development Fund (FEDER) “A way of making Europe” [grant references PI15/00860 to GB, PI17/01482, and PI20/00413 to MP], by the Galician Innovation Agency (GAIN) (Xunta de Galicia, Spain) [grant references IN607A 2016/22 to GB, ED431C-2016/015 and ED431C-2020/14 to RC, ED431C 2021/53 to SL and ED431G 2019/01 and COV20/00604 to RC and SL, by Ministry of Economic Affairs and Digital Transformation (MINECO), Spain [grant references MTM2017-82724-R to RC], by the Spanish Network for Research in Infectious Diseases [REIPI RD16/0016/0006 to GB], by the “Innova Saúde” Program, (INNOVAMICROLAB project) co-founded by the Galician Healthcare Service (SERGAS) and the Spanish Ministry of Science and Innovation, and by the Spanish Network of Research in Infectious Diseases (CIBERINFEC, ISCIII), and by the European Virus Archive Global (EVA-GLOBAL) project that has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement No 871029. SR-F was financially supported by REIPI RD16/0016/006, KC-P by IN607A 2016/22 and the Spanish Association against Cancer (AECC) and JAV by IN607A 2016/22. DP was funded by grant EPICOVIGAL FONDO SUPERA-COVID19 from Banco Santander-CSIC-CRUE, Spain, and grant CT850A-2 from (Health Knowledge Agency) ACIS SERGAS from the Consellería de Sanidade of Xunta de Galicia, Spain., EDAR Bens S.A.; INV04020, EDAR Bens S.A.; INV12120, EDAR Bens S.A.; INV05921, EDAR Bens S.A.; INV148721, Xunta de Galicia; IN607A 2016/22, Xunta de Galicia; ED431C-2016/015, Xunta de Galicia; ED431C-2020/14, Xunta de Galicia; ED431C 2021/53, Xunta de Galicia; ED431G 2019/01, Xunta de Galicia; COV20/00604
RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

The Multispecies Microbial Cluster of Fusobacterium, Parvimonas, Bacteroides and Faecalibacterium as a Precision Biomarker for Colorectal Cancer Diagnosis

  • Ladra, Susana
  • Poza, Margarita
  • Conde-Pérez, Kelly
  • Aja-Macaya, Pablo
  • Buetas, Elena
  • Trigo Tasende, Noelia
  • Nasser-Ali, Mohammed
  • Rumbo-Feal, Soraya
  • Nión, P.
  • Martin-De Arribas, E.
  • Estévez, Lara
  • Otero Alén, Begoña
  • Noguera, José
  • Concha López, Ángel
  • Pardiñas López, Simón
  • Carda-Diéguez, Miguel
  • Gómez-Randulfe, Igor
  • Martínez-Lago, Nieves
  • Antón-Aparicio, Luis M.
  • Bou, Germán
  • Mira, Alex
  • Vallejo, J. A.
[Abstract] The incidence of colorectal cancer (CRC) has increased worldwide, and early diagnosis is crucial to reduce mortality rates. Therefore, new noninvasive biomarkers for CRC are required. Recent studies have revealed an imbalance in the oral and gut microbiomes of patients with CRC, as well as impaired gut vascular barrier function. In the present study, the microbiomes of saliva, crevicular fluid, feces, and non-neoplastic and tumor intestinal tissue samples of 93 CRC patients and 30 healthy individuals without digestive disorders (non-CRC) were analyzed by 16S rRNA metabarcoding procedures. The data revealed that Parvimonas, Fusobacterium, and Bacteroides fragilis were significantly over-represented in stool samples of CRC patients, whereas Faecalibacterium and Blautia were significantly over-abundant in the non-CRC group. Moreover, the tumor samples were enriched in well-known periodontal anaerobes, including Fusobacterium, Parvimonas, Peptostreptococcus, Porphyromonas, and Prevotella. Co-occurrence patterns of these oral microorganisms were observed in the subgingival pocket and in the tumor tissues of CRC patients, where they also correlated with other gut microbes, such as Hungatella. This study provides new evidence that oral pathobionts, normally located in subgingival pockets, can migrate to the colon and probably aggregate with aerobic bacteria, forming synergistic consortia. Furthermore, we suggest that the group composed of Fusobacterium, Parvimonas, Bacteroides, and Faecalibacterium could be used to design an excellent noninvasive fecal test for the early diagnosis of CRC. The combination of these four genera would significantly improve the reliability of a discriminatory test with respect to others that use a single species as a unique CRC biomarker., The authors want to appreciate the good disposition of all the CRC patients for collaborating with us. We would like to thank Gema Carro Díaz and Montserrat Ingelmo Sánchez for their assistance during patients' recruitment time and also during tissue sample collection. This work would not be possible without the support of professionals from the Microbiology, Surgery, Pathology and Oncology Services and Biobank of CHUAC (Spain). The present study received funding from the Instituto de Salud Carlos III (ISCIII), Spain, through the project PI20/00413, cofunded by the European Union (EU) to MP. The whole work has been also supported by the project RTI2018-102032-B-I00 from the Spanish Ministry of Science and Innovation to AM and by CIBER INFEC ISCIII (CB21/13/00055) to GB and MP Biobank of A Coruña was supported by ISCIII-Fondos FEDER (EU) by grant PT20/00128. KC-P was financially supported by the Spanish Association against Cancer (AECC). EB was supported by a grant from the Spanish Ministry of Science and Innovation PRE2019-088126. SL and EM-DA were supported by grants from GAIN (Xunta de Galicia, Spain) with references ED431C 2021/53 and ED431G 2019/01., Xunta de Galicia; ED431C 2021/53, Xunta de Galicia; ED431G 2019/01
RUC. Repositorio da Universidade da Coruña
Publicación Contribución de congreso (ConferenceOutput)

Machine Learning Decodes the Microbiome: Advancing Diagnostic Accuracy in Gastrointestinal Diseases

  • Wasim, Ayesha
  • Martin-De Arribas, E.
  • Ladra, Susana
  • Poza, Margarita
  • Fernández-Lozano, Carlos
Presentado en: 11th ISM World Congress on Targeting Microbiota, 14-15 October 2024, Malta Versión aceptada, [Abstract]: This study evaluates the diagnostic accuracy of machine learning (ML) models on gut microbiome data for gastrointestinal diseases. By assessing batch correction and profiling strategies, the results show that species-level taxonomic features excel for Crohn's disease, whereas ComBat-seq batch correction improves predictive accuracy in colorectal cancer. Algorithms like Random Forest and XGBoost proved most effective, offering guidance for reproducible non-invasive diagnostics., Spanish Ministry of Science and Innovation with funds from the European Union NextGenerationEU, Horizon 2020 research and innovation programme under a Marie Skłodowska-Curie agreement 101034261 (H2020-MSCA-COFUND), from GAIN and MRR funds, Recovery, Transformation and Resilience Plan (PRTRC17.I1), NextGenerationEU (DATAMICROCCR); MCIN/AEI/10.13039/501100011033, GAIN/Xunta de Galicia (GRC: ED431C 2021/53). The present study received funding from the Instituto de Salud Carlos III (ISCIII), Spain, through the projects PI20/00413 and PI23/00696, cofounded by the European Union (EU) to MP., Xunta de Galicia; ED431C 2021/53
RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

Microbiome in Immune-Mediated Uveitis

  • Poza, Margarita
  • Rodríguez-Fernández, Carmen Antía
  • Busto Iglesias, Manuel
  • Domingo, Begoña de
  • Conde-Pérez, Kelly
  • Vallejo, J. A.
  • Rodríguez Martínez, Lorena
  • González Barcia, Miguel
  • Llorenç, Victor
  • Mondelo-García, Cristina
  • Fernández Ferreiro, Anxo
[Abstract] In the last decades, personalized medicine has been increasing its presence in different fields of medicine, including ophthalmology. A new factor that can help us direct medicine towards the challenge of personalized treatments is the microbiome. The gut microbiome plays an important role in controlling immune response, and dysbiosis has been associated with immune-mediated diseases such as non-infectious uveitis (NIU). In this review, we gather the published evidence, both in the pre-clinical and clinical studies, that support the possible role of intestinal dysbiosis in the pathogenesis of NIU, as well as the modulation of the gut microbiota as a new possible therapeutic target. We describe the different mechanisms that have been proposed to involve dysbiosis in the causality of NIU, as well as the potential pharmacological tools that could be used to modify the microbiome (dietary supplementation, antibiotics, fecal microbiota transplantation, immunomodulators, or biologic drugs) and, consequently, in the control of the NIU. Furthermore, there is increasing scientific evidence suggesting that the treatment with anti-TNF not only restores the composition of the gut microbiota but also that the study of the composition of the gut microbiome will help predict the response of each patient to anti-TNF treatment., Funding This work was partially supported by ISCIII co-funded by FEDER (PI20/00719, PI20/00413) and by Xunta de Galicia IN607D 2021 and IN607A 2020/05. Acknowledgments CMG and AFF acknowledge the support of Instituto de Salud Carlos III (ISCIII) by research grants (JR20/0026 and JR18/00014)., Xunta de Galicia; IN607D 2021, Xunta de Galicia; IN607A 2020/05
RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

Building-Scale Wastewater-Based Epidemiology for SARS-CoV-2 Surveillance at Nursing Homes in A Coruña, Spain

  • Trigo Tasende, Noelia
  • Vallejo, J. A.
  • Rumbo-Feal, Soraya
  • Conde-Pérez, Kelly
  • Nasser-Ali, Mohammed
  • Tarrío-Saavedra, Javier
  • Barbeito, Inés
  • Cao, Ricardo
  • Ladra, Susana
  • Bou, Germán
  • Poza, Margarita
Financiado para publicación en acceso aberto: Universidade da Coruña/CISUG, [Abstract] Wastewater-based epidemiology (WBE) has become an effective tool in the surveillance of infectious diseases such as COVID-19. In this work, we performed a brief study of monitoring the SARS-CoV-2 viral load in wastewater from six nursing homes located in the metropolitan area of A Coruña (Spain) between December 2020 and March 2021. The main objective was to detect SARSCoV- 2 outbreaks among residents and study the efficacy of the vaccination campaign. SARS-CoV-2 viral load (RNA copies per L of wastewater) was determined by reverse-transcription quantitative PCR (RT-qPCR) using the quantification cycle (Cq) values for the nucleocapsid (N) gene. Our results showed that the increase in viral load preceded the increase in clinical cases, favoring an early warning system that detects COVID-19 outbreaks in advance, making it possible to contain and stop the transmission of the virus among residents. In addition, the efficacy of the new COVID-19 vaccines was evidenced, since after the vaccination campaign in nursing homes in A Coruña, it was observed that many residents did not present any symptoms of the disease, although they excreted high amounts of virus in their feces. WBE is a cost-effective strategy that should be implemented in all cities to prevent new emerging diseases or future pandemic threats., EDAR Bens S.A.; INV04020, EDAR Bens S.A.; INV12120, EDAR Bens S.A.; INV05921, EDAR Bens S.A.; INV148721, Xunta de Galicia; IN607A 2016/22, Xunta de Galicia; ED431C-2016/015, Xunta de Galicia; ED431C-2020/14, Xunta de Galicia; ED431C 2021/53, Xunta de Galicia; ED431G 2019/01, Xunta de Galicia; COV20/00604, Funding for open access charge: Universidade da Coruña/CISUG. This work was mainly supported by the grant INV00821 from Consellería de Política Social (Xunta de Galicia, Spain) to M.P. The team was also supported by EDAR Bens S.A., A Coruña, Spain (grant references INV04020, INV12120, INV05921, and INV148721 to M.P.), by the National Plan for Scientific Research, Development and Technological Innovation funded by the Institute of Health Carlos III (ISCIII), Spain—General Subdirection of Assessment and Promotion of the Research-European Regional Development Fund (FEDER) “A way of making Europe” [grant references PI15/00860 to G.B., PI17/01482 and PI20/00413 to M.P.], by the Galician Innovation Agency (GAIN) (Xunta de Galicia, Spain) [grant references IN607A 2016/22 to G.B., ED431C-2016/015 and ED431C-2020/14 to R.C., ED431C 2021/53 to S.L., and ED431G 2019/01 and COV20/00604 to R.C. and S.L., by the Ministry of Economic Affairs and Digital Transformation (MINECO), Spain (grant references MTM2017-82724-R to R.C.), by the Spanish Network of Research in Infectious Diseases (CIBERINFEC, ISCIII, reference CB21/13/00055), and by the European Virus Archive Global (EVA-GLOBAL) project that has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement No 871029. S.R.-F. was financially supported by REIPI RD16/0016/006, K.C.-P. by IN607A 2016/22 and the Spanish Association against Cancer (AECC), and J.A.V. by IN607A 2016/22.
RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

Anti-inflammatory and Antimicrobial Efficacy of Coconut Oil for Periodontal Pathogens: A Triple-Blind Randomized Clinical Trial

  • Pardiñas López, Simón
  • García-Caro, Mónica E.
  • Vallejo, J. A.
  • Aja-Macaya, Pablo
  • Conde-Pérez, Kelly
  • Nión, P.
  • Khouly, Ismael
  • Bou, Germán
  • Rodríguez-Cendal, Ana Isabel
  • Díaz-Prado, Silvia
  • Poza, Margarita
Randomized controlled trial, Financiado para publicación en acceso aberto: Universidade da Coruña/CISUG, [Abstract] Objectives: To evaluate the effect of coconut oil on the oral bacteriome and inflammatory response in patients with periodontitis by integrating next-generation sequencing analyses of pathogenic bacterial shifts and quantification of inflammatory markers, thereby assessing its potential as a natural adjunct to standard nonsurgical periodontal therapy. Materials and methods: A triple-blind clinical trial was conducted with 30 participants diagnosed with periodontitis, randomized into 3 groups: (1) coconut oil, (2) chlorhexidine and (3) placebo. Saliva and gingival crevicular fluid (GCF) samples were collected before treatment, one month after treatment, and one month post-non-surgical periodontal therapy. Bacterial DNA was extracted, and the V3-V4 region of the 16 S rRNA gene was PCR-amplified and sequenced using Illumina MiSeq technologies. Inflammatory biomarkers, including Interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α), were quantified from GCF samples. Results: Coconut oil treatment significantly reduced pathogenic bacterial families such as Spirochaetaceae and Tannerellaceae while promoting beneficial bacteria such as Streptococcaceae. At the genus and species levels, coconut oil reduced pathogens such as Tannerella forsythia and Treponema denticola along with increase in beneficial bacteria such as Streptococcus. The subgingival microbial dysbiosis index improved significantly in both coconut oil and chlorhexidine groups. Furthermore, the coconut oil demonstrated a reduction in IL-6 and TNF-α levels, indicating decreased local inflammation. Conclusions: Coconut oil treatment significantly modulated the oral microbiome and reduced inflammatory markers in patients with periodontitis, suggesting its potential as a natural and effective adjunct in periodontal therapy. Clinical relevance: This study highlights coconut oil's potential as a natural adjunct in periodontal therapy, effectively reducing pathogenic bacteria and inflammatory markers (IL-6, TNF-α). It offers a safe alternative to chlorhexidine, promoting microbiome balance and improved periodontal health., Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature. The present study received funding from the Instituto de Salud Carlos III (ISCIII), Spain, through the projects PI20/00413 and PI23/00696, co-funded by the European Union (EU), to M. P and by CIBER de Enfermedades Infecciosas CIBERINFEC, ISCIII (CB21/13/00055) to G. B and M. P. Grupos con Potencial de Crecemento from Xunta de Galicia, Galicia, Spain (ED431B 2023/58 and ED431B 2020/55) and Fundación Pública Galega de Investigación Biomédica (FINIBIC). Funding for open access charge: Universidade da Coruña/CISUG., Xunta de Galicia; ED431B 2023/58, Xunta de Galicia; ED431B 2020/55
RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

Parvimonas Micra Can Translocate From the Subgingival Sulcus of the Human Oral Cavity to Colorectal Adenocarcinoma

  • Conde-Pérez, Kelly
  • Buetas, Elena
  • Aja-Macaya, Pablo
  • Martin-De Arribas, E.
  • Iglesias Corrás, Iago
  • Trigo Tasende, Noelia
  • Nasser-Ali, Mohammed
  • Estévez, Lara
  • Rumbo-Feal, Soraya
  • Otero Alén, Begoña
  • Noguera, José
  • Concha López, Ángel
  • Pardiñas López, Simón
  • Carda-Diéguez, Miguel
  • Gómez-Randulfe, Igor
  • Martínez-Lago, Nieves
  • Ladra, Susana
  • Antón-Aparicio, Luis M.
  • Bou, Germán
  • Mira, Alex
  • Vallejo, J. A.
  • Poza, Margarita
[Abstract] Oral and intestinal samples from a cohort of 93 colorectal cancer (CRC) patients and 30 healthy controls (non-CRC) were collected for microbiome analysis. Saliva (28 non-CRC and 94 CRC), feces (30 non-CRC and 97 CRC), subgingival fluid (20 CRC), and tumor tissue samples (20 CRC) were used for 16S metabarcoding and/or RNA sequencing (RNAseq) approaches. A differential analysis of the abundance, performed with the ANCOM-BC package, adjusting the P-values by the Holm-Bonferroni method, revealed that Parvimonas was significantly over-represented in feces from CRC patients (P-value < 0.001) compared to healthy controls. A total of 11 Parvimonas micra isolates were obtained from the oral cavity and adenocarcinoma of CRC patients. Genome analysis identified a pair of isolates from the same patient that shared 99.2% identity, demonstrating that P. micra can translocate from the subgingival cavity to the gut. The data suggest that P. micra could migrate in a synergistic consortium with other periodontal bacteria. Metatranscriptomics confirmed that oral bacteria were more active in tumor than in non-neoplastic tissues. We suggest that P. micra could be considered as a CRC biomarker detected in non-invasive samples such as feces., This study has been funded by Instituto de Salud Carlos III (ISCIII) through the project PI20/00413 and co-funded by the European Union to MP. The work has been also supported by the project RTI2018-102032-B-I00 from the Spanish Ministry of Science and Innovation to AM and by the CIBER INF ISCIII (CB21/13/00055) to GB and MP. Biobank of University Hospital Complex of A Coruña was supported by Instituto de Salud Carlos III – Fondos FEDER (EU) by grant PT20/00128. K. Conde-Pérez was financially supported with a predoctoral fellowship by the Asociación Española Contra el Cáncer (AECC). E. Buetas is supported by a grant from the Spanish Ministry of Science and Innovation with the reference PRE2019-088126. S. Ladra, E. Martin-De Arribas and Iago Iglesias-Corrás are supported by grants from GAIN (Xunta de Galicia, Spain) with references ED431C 2021/53 and ED431G, Xunta de Galicia; ED431C 2021/53, Xunta de Galicia; ED431G
RUC. Repositorio da Universidade da Coruña
Publicación Tesis doctoral (DoctoralThesis)

Microbioma y cáncer colorrectal: translocación de bacterias orales al intestino y búsqueda de potenciales biomarcadores

  • Conde-Pérez, Kelly
[Resumen] El microbioma humano desempeña un papel esencial en el mantenimiento de las funciones fisiológicas normales. Estudios previos han demostrado la implicación del microbioma en el desarrollo de patologías, tales como el cáncer colorrectal (CCR). En el presente trabajo, se describió el bacterioma de muestras de saliva, fluído crevicular, heces y tejidos de tumores primarios y de metastásis, procedentes de una cohorte de 93 pacientes de CCR, mediante tecnologías de secuenciación de próxima generación. Los resultados obtenidos se compararon con el bacterioma de muestras de individuos sin CCR, con el objetivo principal de comprender la implicación de las bacterias en el desarrollo del CCR. Los resultados mostraron que el microbioma intestinal de pacientes de CCR estaba desequilibrado y enriquecido en patógenos periodontales. Una combinación específica de estos patógenos orales, ausentes en muestras de personas sin CCR, se propone para su uso como biomarcador para el diagnóstico de CCR empleando muestras no invasivas (heces). Uno de estos patógenos, Parvimonas micra, detectado en la cavidad oral y en carcinomas colorrectales, fue estudiado en profundidad, en una cohorte aleatoria de 20 pacientes, demostrándose mediante genómica comparativa, que esta bacteria es capaz de translocarse desde la cavidad subgingival hasta el colon, formando consorcios sinérgicos con otras bacterias., [Resumo] O microbioma humán desempeña un papel esencial no mantemento das funcións fisiolóxicas normais. Estudos previos demostraron a implicación do microbioma no desenvolvemento de diversas patoloxías, tales como o cancro colorrectal (CCR). No presente traballo, describiuse o bacterioma de mostras de saliva, fluído crevicular xinxival, feces e tecidos de tumores primarios e de metastásis, procedentes dunha cohorte de 93 pacientes de CCR, mediante tecnoloxías de secuenciación de próxima xeración. Os resultados obtidos comparáronse co bacterioma de mostras de individuos sen CCR, co obxectivo principal de comprender a implicación das bacterias no desenvolvemento do CCR. Os resultados mostraron que o microbioma intestinal de pacientes con CCR estaba desequilibrado e enriquecido en patóxenos periodontais. Unha combinación específica destes patóxenos orais, ausentes en mostras de persoas sen CCR, proponse para o seu emprego como biomarcador para o diagnóstico de CCR empregando mostras non invasivas (feces). Un destes patógenos, Parvimonas micra, detectado na cavidade oral e nos carcinomas colorrectais, foi estudado en profundidade nunha cohorte aleatoria de 20 pacientes, demostrándose, mediante xenómica comparativa, que esta bacteria é capaz de translocarse desde a cavidade subxinxival ata o colon, formando consorcios sinérxicos con outras bacterias., [Abstract] The human microbiome plays an essential role in maintaining normal physiological functions. Previous studies have demonstrated its involvement in the development of different diseases such as colorectal cancer (CCR). This study used next-generation sequencing technologies to characterize the bacteriome of saliva, gingival crevicular fluid, feces, primary tumor tissues, and metastatic tissues from a cohort of 93 CRC patients. The results obtained were compared with bacteriome profiles of samples from a group of individuals without CCR, with the main objective of understanding the role of oral and gut bacteria in the CCR development. The findings revealed an imbalanced and a periodontal pathogen-enrichment in the intestinal microbiome of CCR patients. Notably, a specific combination of oral pathogens, absent in no CCR individuals, was identified as a potential biomarker for non-invasive CCR diagnosis using fecal samples. Among these pathogens, Parvimonas micra, detected in the oral cavity and in colorectal carcinomas, was extensively studied in a randomized cohort of 20 CCR patients. Comparative genome analysis demonstrated that this bacterium was able to translocate from the subgingival cavity to the colon forming synergistic consortia with other oral bacteria.
RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

A New and Efficient Enrichment Method for Metagenomic Sequencing of Monkeypox Virus

  • Aja-Macaya, Pablo
  • Rumbo-Feal, Soraya
  • Poza, Margarita
  • Cañizares, Angelina
  • Vallejo, J. A.
  • Bou, Germán
[Abstract] Background The methodology described in previous literature for Monkeypox virus (MPXV) sequencing shows low efficiency when using metagenomic approaches. The aim of the present study was to evaluate a new fine-tuned method for extraction and enrichment of genomic MPXV DNA using clinical samples and to compare it to a non-enrichment metagenomic approach. Results A new procedure that allows sample enrichment in MPXV DNA, avoiding wasting the sequencing capacity in human DNA, was designed. This procedure consisted of host DNA depletion using a saponin/NaCl combination treatment and DNase, together with high g-force centrifugations. After typical quality control, samples using the enrichment method contained around 96% of reads not classified as human DNA, while the non-enrichment protocol showed around 5-10%. When reads not belonging to Orthopoxvirus were removed, enriched samples kept about 50% of the original read counts, while non-enriched ones kept only 2-7%. Conclusions Results showed a very significant improvement in sequencing efficiency, increasing the number of reads belonging to MPXV, the depth of coverage and the trustworthiness of the consensus sequences. This, in turn, allows for more samples to be included in a single cartridge, reducing costs and time to diagnosis, which can be very important factors when dealing with a contagious disease., This work was supported by a grant from the SERGAS-Galician Healthcare Service (Program “Innova Saúde”) to GB, by CIBERINFEC and also by Instituto de Salud Carlos III (ISCIII) through the projects PI20/00413 to MP and PI21/00704 to GB
RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

Nanopore full length 16S rRNA gene sequencing increases species resolution in bacterial biomarker discovery

  • Aja-Macaya, Pablo
  • Conde-Pérez, Kelly
  • Noelia Trigo-Tasende
  • Nasser-Ali, Mohammed
  • Nión, P.
  • Rumbo-Feal, Soraya
  • Ladra, Susana
  • Bou, Germán
  • Vallejo, J. A.
  • Poza, Margarita
Raw sequence reads generated from 16S rRNA gene sequencing by MiSeq (Illumina-V3V4) and MinION (ONT-V1V9, Dorado sup v4.1.0) are available in the NCBI SRA database under bioproject PRJNA911189. Used scripts and additional documentation are available at https://github.com/Pablo-Aja-Macaya/CRC-ONT16S., [Abstract]: Discovery of disease-related bacterial biomarkers could be a useful approach for early prevention or diagnosis of various afflictions, such as colorectal cancer. This typically involves analyzing small regions of the 16S rRNA gene (e.g. V3V4) through short-read technologies like Illumina, obtaining genus-level results. However, recent developments in third-generation sequencing, such as Oxford Nanopore Technologies (ONT)’s new R10.4.1 chemistry and its improved basecalling models, are beginning to allow for a more complete and accessible species-level analysis through full-length 16S rRNA gene sequencing (spanning regions V1-V9). Thus, the goal of this study was to compare and evaluate both approaches, using colorectal cancer biomarker discovery as a representative case. This was achieved through the analysis of feces from 123 subjects, comparing both methods (Illumina-V3V4 with DADA2 and QIIME2 vs. ONT-V1V9 with Emu), multiple Dorado basecalling models (fast, hac and sup) and multiple databases (SILVA vs. Emu’s Default database). Basecalling models broadly resulted in similar taxonomic output, but had significantly higher observed species and different taxonomic identification the lower the basecalling quality (p-value<0.05). Database choice with Emu influenced the identified species greatly, with Emu’s Default database obtaining significantly higher diversity and identified species than SILVA (p-value<0.05). However, it overconfidently classified at times what should be an unknown species as the closest match due to its database structure. Bacterial abundance between Illumina-V3V4 and ONT-V1V9 at the genus level correlated well (R2 0.8). Nanopore sequencing identified more specific bacterial biomarkers for colorectal cancer than those obtained with Illumina, such as Parvimonas micra, Fusobacterium nucleatum, Peptostreptococcus stomatis, Peptostreptococcus anaerobius, Gemella morbillorum, Clostridium perfringens, Bacteroides fragilis and Sutterella wadsworthensis. Prediction of colorectal cancer through manual feature selection and machine learning resulted in an AUC of 0.87 with 14 species or 0.82 with just 4 species (P. micra, F. nucleatum, B. fragilis and Agathobaculum butyriciproducens). Full 16S rRNA V1V9 sequencing through Oxford Nanopore and its new R10.4.1 chemistry achieved accurate species-level bacterial identification, facilitating the discovery of more precise disease-related biomarkers and increasing the taxonomic fidelity of future microbiome analyses., This study has been funded by the Instituto de Salud Carlos III (ISCIII), through the projects PI20/00413 and PI23/00696, cofunded by the European Union (EU) to MP. Also, the work was funded by the project IN607A2024/09 from Xunta de Galicia (Spain) to GB. Additionally, it has been supported by the project RTI2018-102032-B-I00 from the Spanish Ministry of Science and Innovation to AM and by CIBER INFEC ISCIII (CB21/13/00055) to GB and MP. KC-P was financially supported by the Spanish Association against Cancer (AECC) from December 2019 to December 2023. Additionally, this work, integrated into the framework of PERTE for Vanguard Health, has been co-financed by the Spanish Ministry of Science, Innovation and Universities with funds from the European Union NextGenerationEU, from the Recovery, Transformation and Resilience Plan (PRTR-C17.I1) and from the Autonomous Community of Galicia within the framework of the Biotechnology Plan Applied to Health to SL., Xunta de Galicia; IN607A2024/09